Package 42192-619-16

{"route": ["ORAL"], "spl_id": "47a98b71-a338-b13d-e063-6394a90a96f6", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0342192619166"], "unii": ["57Y76R9ATQ"], "rxcui": ["311913"], "spl_set_id": ["7e6f03fb-4b36-4418-9684-f45637abbb78"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (42192-619-16)", "package_ndc": "42192-619-16", "marketing_end_date": "20280131", "marketing_start_date": "20201112"}], "brand_name": "Naproxen", "product_id": "42192-619_47a98b71-a338-b13d-e063-6394a90a96f6", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "42192-619", "generic_name": "Naproxen", "labeler_name": "Acella Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen", "active_ingredients": [{"name": "NAPROXEN", "strength": "125 mg/5mL"}], "application_number": "NDA018965", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20280131", "marketing_start_date": "20201112"}